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Summary
It has been suggested that substrate adhesion molecules
of the tenascin family may be responsible for the
segmented outgrowth of motor axons and neural crest
cells during formation of the peripheral nervous system.
We have used two monoclonal antibodies (M1B4 and
578) and an antiserum [KAF9(1)] to study the expression
of Jl/tenascin-related molecules within the somites of
the chick embryo. Neural crest cells were identified with
monoclonal antibodies HNK-1 and 20B4. Young somites
are surrounded by Jl/tenascin immunoreactive ma-
terial, while old sclerotomes are immunoreactive pre-
dominantly in their rostral halves, as described by other
authors (Tan et al. 1987 - Proc. natn. Acad. Sci. U.S.A.
84, 7977; Mackie et al. 1988 - Development 102, 237). At
intermediate stages of development, however, immuno-
reactivity is found mainly in the caudal half of each
sclerotome. After ablation of the neural crest, the
pattern of immunoreactivity is no longer localised to the
rostral halves of the older, neural-crest-free sclerotomes.
SDS-polyacrylamide gel electrophoresis of affinity-puri-
fied somite tissue, extracted using M1B4 antibody,
shows a characteristic set of bands, including one of
about 230xlO3, as described for cytotactin, Jl-200/220
and the monomeric form of tenascin. Affinity-purified
somite material obtained from neural-crest-ablated
somites reveals some of the bands seen in older control
embryos, but the high molecular weight components
(120-230X103) are missing. Young epithelial somites
also lack the higher molecular mass components. The
neural crest may therefore participate in the expression
of Jl/tenascin-related molecules in the chick embryo.
These results suggest that these molecules are not
directly responsible for the segmented outgrowth of
precursors of the peripheral nervous system.
Key words: tenascin, cytotactin, Jl, segmentation, somites,
neural crest, motor axons, peripheral nervous system,
substrate-adhesion molecules (SAMs).
Introduction
The peripheral nervous system of higher vertebrate
embryos becomes segmented because neural crest cells
and motor axons emerging from the developing spinal
cord are restricted in their migration to the rostral half
of each adjacent sclerotome (Keynes and Stern, 1984;
reviewed by Keynes and Stern, 1988). The study of the
interactions between precursors of the peripheral ner-
vous system and somite tissue therefore constitutes an
apparently simple model system for the investigation of
factors controlling patterning in the developing nervous
system. Recently, our laboratories and others have set
out to find macromolecules that are differentially ex-
pressed in the two halves of the sclerotome, with the
aim of identifying those that have a function in control-
ling the segmental pattern (Stern et al. 1986; Tosney et
al. 1987; Tan et al. 1987; Mackie et al. 1988; Layer et al.
1988; Norris et al. 1989; Halfter et al. 1989).
One recent paper (Tan et al. 1987) reported that the
glycoprotein cytotactin (main Mr = 190-220xlO3; Gru-
met et al. 1985; Hoffman et al. 1988) is restricted to the
rostral halves of the sclerotomes of the chick embryo,
while a cytotactin-binding proteoglycan (CTB-proteo-
glycan; Hoffman and Edelman, 1987) is restricted to the
caudal halves. Tan etal. (1987) suggested that cytotactin
and its proteoglycan ligand 'may control the pattern of
neural crest migration'. However, several of their results
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suggest that the relationship between neural crest
migration and the expression of these macromolecules
is not straightforward. First, cytotactin is not localised
to the rostral halves of the sclerotomes present before
stage 16 (Hamburger and Hamilton, 1951) or so, at
which time the neural crest has already entered the
rostral halves of these sclerotomes (Thiery et al. 1982;
Rickmann etal. 1985; Bronner-Fraser, 1986; Loring and
Erickson, 1987; Teillet et al. 1987. cf. Crossin et al.
1986); second, paradoxically, cytotactin substrates in-
hibit neural crest migration and spreading in vitro;
third, it seems curious that while cytotactin is restricted
to the rostral half of the sclerotome, its proteoglycan
ligand becomes localised to the opposite half after the
appearance of cytotactin.
Comparable results were obtained by another group
of workers (Mackie et al. 1988), who investigated the
distribution of tenascin (Chiquet and Fambrough, 1984;
Mackie et al. 1987), a hexamer of glycoproteins of
similar molecular mass to cytotactin (Vaughan et al.
1987), in the sclerotome of the quail embryo. They, too,
found that tenascin is restricted to the rostral halves of
the sclerotomes after stage 16 (Mackie etal. 1988), and
that tenascin substrates inhibit neural crest migration
and spreading in vitro when cultured on basal laminae
(Mackie et al. 1988; Halfter et al. 1989).
It seems likely that cytotactin and tenascin, as well as
two other glycoproteins, Jl 200/220 (Kruse et al. 1985;
Faissner et al. 1988) and GMEM (glioma extracellular
matrix molecule; Bourdon etal. 1985) are related, if not
identical (see Aufderheide and Ekblom, 1988; Faissner
et al. 1988; Friedlander et al. 1988; Hoffman et al. 1988;
Mackie et al. 1988; Halfter et al. 1989). Their relative
molecular masses appear to be the same; all of them
comprise several polypeptides of various relative mol-
ecular masses between 110 and 260 X103, with a pre-
dominant band at Mr = 220xl03, and both cytotactin
and tenascin are assembled as a hexamer, called a
'hexabrachiori (Friedlander et al. 1988). Tenascin and
Jl have been reported to be related immunologically,
and cytotactin and tenascin show apparently identical
patterns of immunohistological localisation in various
tissues (see Mackie et al. 1988), as well as identical
effects on neural crest cells in vitro. At least when
isolated from brain, cytotactin and its proteoglycan
ligand can carry the HNK-1/L2 carbohydrate epitope
(Hoffman and Edelman, 1987; Kunemund et al. 1988;
Friedlander et al. 1988; Hoffman et al. 1988), as does Jl
(Kruse et al. 1985; Faissner et al. 1988).
In this study, we have used three different antibodies,
two monoclonals (M1B4 - Chiquet and Fambrough,
1984 and MAb578 - Faissner et al. 1988 and in prep-
aration) and one antiserum (KAF9(1); Faissner et al.
1988 and in preparation), to study the distribution of
Jl/tenascin-related molecules in the sclerotome of the
chick embryo in more detail. We performed neural
crest ablations to examine the relationship between the
position of neural crest cells and the expression of these
molecules, and constructed an M1B4 affinity column to
purify the antigens for subsequent identification by
SDS-polyacrylamide gel electrophoresis.
Materials and methods
Embryos and operations
Fertile hens' eggs (Rhode Island Red hybrids) were incubated
at 38 °C for 2-3 days until they had reached Hamburger and
Hamilton (1951) stages 10-20. Embryos destined for ablation
of the neural crest were treated as follows: at about stage
10-12, a l-5xl-5cm window was cut in the egg shell with a
scalpel, the embryo floated up to the level of the shell with
calcium- and magnesium-free Tyrode's saline (CMF), and
about 50^1 of a 1:10 solution of Indian ink (Pelikan Fount
India) in CMF injected into the subblastodermic cavity, to
improve contrast between the embryo and the underlying
yolk. Removal of the neural crest was then performed, under
a drop of CMF, using a microsurgical knife (Week, 15° angle),
Dewecker's scissors and a steel needle made from a N°l
entomological pin. The dorsal half of the neural tube spanning
the region between the caudal end of the segmental plate and
the 4th most recently formed somite (corresponding to some
14 segments in length) was excised. The ventral half of the
tube and the underlying notochord were left in place. After
the operation, the CMF was removed from above the embryo,
and about 2 ml thin albumen withdrawn with a syringe from a
hole in the blunt end of the egg; this lowered the embryo back
into the shell. The shell was then sealed with PVC tape and
the egg incubated at 38°C for a further 36-48 h, by which time
the embryos had reached stages 17-22. Three additional
embryos were incubated for a longer period, until they had
reached stages 25-27.
Control embryos were treated in an identical manner: the
vitelline membrane was cut above the embryo and, in most
cases, deep cuts were made on either side of the neural tube.
After these manipulations, the embryos were lowered into the
shell, the eggs sealed and incubated exactly as for operated
embryos. All of the 107 operated embryos and 116 controls
survived the subsequent period of incubation.
Immunohistochemistry
Control and operated embryos destined for immunohisto-
chemistry were fixed in 100% ethanol for lh or in buffered
formol saline (4 % formaldehyde in phosphate-buffered saline
[PBS]) for 30 min, and washed well with PBS. They were then
placed in a 5 % solution of sucrose in PBS for 1-3 h, then in
20% sucrose/PBS for 8-24h, and finally infiltrated for 2-6h
at 38°C with a solution containing 7-5% gelatin (Sigma, 300
Bloom) and 15 % sucrose in PBS. They were then brought to
room temperature, to allow the blocks to set. These blocks
were stored at 4°C for no longer than a week prior to serial
sectioning (5-10pun) at -20°C in a Bright cryostat. The
sections were collected on gelatinised glass slides, air dried
and stored at 4°C until required.
Prior to immunohistochemical staining, the sections were
rehydrated and the gelatin removed by placing them in PBS at
38°C for a few minutes, then washed extensively with PBS.
They were then blocked with 3% bovine serum albumin
(BSA, Sigma) for 20 min, placed in the appropriate antibody
(see below) for lh at room temperature, washed extensively
with PBS, placed in the appropriate labelled secondary
antibody for 1 h at room temperature, washed again, and then
processed for immunofluorescence or immunoperoxidase.
For immunofluorescence, the slides were mounted in a
nonquenching medium (14% Gelvatol 20/30 [Fisons] con-
taining 8'5ragmr' diazobicyclo-octane [DABCO, Aldrich,
as anti-quenching agent], 30% glycerol and 350/.tgml"1
sodium azide as preservative in PBS, pH6-8), and viewed and
photographed under epifluorescence optics in an Olympus
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Vanox-T microscope, using supplementary exciter and barrier
filters to minimise spill-over between fluorescein and rhoda-
mine wavelengths. The supplementary filter combinations
used were: excitation EY455/emission B460 for fluorescein
(blue excitation, green pass) and excitation EO530/emission
O590 for rhodamine (green excitation, red pass). Lack of
spill-over may be confirmed by the reader by viewing the
colour figures with red/green glasses.
For immunoperoxidase, the slides were washed briefly in
O-lM-Tris-HCl and then incubated in a 500jUgml~' solution
of diaminobenzidine (Aldrich), to which H2C>2 was added to a
final concentration of 0-3 %. The slides were incubated in this
for about lOmin at room temperature, then washed in
running tap water for 30min, rinsed in distilled water and
mounted in Aquamount medium (BDH).
Antibodies
Neural crest cells present within the sclerotome of chick and
quail embryos display the HNK-1/L2 epitope, and therefore
monoclonal antibodies specific for this epitope (such as NC-1
or HNK-1; Tucker et al. 1984) are often used to detect the
presence of neural crest cells in histological sections. Bronner-
Fraser (1986) and Teillet et al. (1987) have investigated the
expression of the HNK-1 epitope in neural crest cells in the
chick embryo in some detail, conclude that almost all the crest
cells that traverse the sclerotome express HNK-1 immuno-
reactivity (unlike some crest cells in the head and some that
take the dorsolateral pathway between the ectoderm and the
somite); HNK-1 is therefore a good marker for neural crest
cells present in the sclerotome at this stage of development.
Since Jl/tenascin-related molecules can carry the HNK-1/L2
epitope, we have used antibody 20B4 (which recognises a
different, as yet uncharacterised, epitope expressed by neural
crest cells; Dr J. Denburg, unpublished data) in addition to
HNK-1 to detect neural crest cells and to control for the
possibility of cross-reaction between the HNK-1 antibody and
Jl/tenascin-related molecules.
The primary antibodies used (dilutions in 0-3 % BSA/PBS)
were:
M1B4 supernatant (Mouse igG, originally raised by Dr
Douglas Fambrough and obtained from the Developmental
Studies Hybridoma Bank). This was used at concentrations
between 1 and lO^gm!" (between 1:10 dilution and undi-
luted). The antibody recognises the original 'myotendinous
antigen' (= tenascin = hexabrachion) described by Chiquet
and Fambrough (1984; see also Friedlander et al. 1988) and an
epitope near the carboxy-terminal end of chain I of the
cytotactin molecule (Friedlander et al. 1988).
578 purified ascites (Rat IgG monoclonal against Jl 200/220;
Faissner et al. 1988 and in preparation). Used at 1:100
1
(g
KAF9(J) (IgG fraction of rabbit antiserum directed against
mouse Jl 200/220-tenascin; Faissner et al. 1988 and in
preparation). Used at 1:200 (25/*gml"').
HNK-1 supernatant (Mouse IgM, originally raised by Abo and
Balch, 1981). Used 1:2 or undiluted (about 50/igml"1). The
neural crest specificity of this antibody is discussed by various
authors (e.g. Tucker et al. 1984; Rickmann et al. 1985;
Bronner-Fraser, 1986; Teillet et al. 1987; Canning and Stern,
1988).
20B4 supernatant (Mouse IgG, originally raised by Dr Jeff
Denburg, to chick dorsal root ganglion cells and obtained
from the Developmental Studies Hybridoma Bank). Used
undiluted (20^gmr').
In double-immunofluorescence studies, it was important to
use secondary antibodies that did not cross-react across
species or immunoglobulin types. After extensive tests to
ascertain this, the following antibodies were selected:
For mouse IgG: (1) affinity-purified tetramethylrhodamine
isothiocyanate (TRITC)-labelled goat anti-mouse IgG (Fc
fragment specific; Sigma), used at 1:50 or (2) IgG fraction of
affinity-purified fluorescein isothiocyanate (FITC)-labelled
goat anti-mouse IgG (Fc fragment, y-chain specific; Cappel).
Used at 1:50 or 1:100.
For mouse IgM: (1) affinity-purified FITC-labelled goat anti-
mouse IgM (ju-chain specific; Sigma), used at 1:100, or (2)
TRITC-labelled sheep anti-mouse IgM (Fc fragment specific;
Serotec), used at 1:40.
For rat IgG: affinity-purified TRITC- or FITC-labelled goat
anti-rat IgG (Fc fragment specific, tested for the absence of
cross-reactivity to mouse IgG by the manufacturers; Cappel
1213-1721). We confirmed the absence of cross-reactivity
between this antibody and mouse IgG ourselves in sections
that had been incubated with mouse monoclonals M1B4 or
20B4. Used at a dilution of 1:100 (30^gml~').
For rabbit IgG: affinity-purified TRITC- or FITC-labelled
goat anti-rabbit IgG (Fey chain specific; Cappel), used at 1:50
(20/igmr1).
To absorb out any remaining nonspecific binding, all
secondary antibodies were made up in 0-3% BSA in PBS
containing 1-5% normal goat serum, and the final working
solution absorbed against either fresh or formalin-fixed 2-day
chick embryo tissues for 30min under gentle agitation at room
temperature; after this, the working solution was centrifuged
for 3min at lOOg in a Micro-Centaur centrifuge. These
procedures were necessary to remove components of the
secondary antisera that were found to bind to various chick
tissues. In double-immunofluorescence experiments, the two
primary antibodies were added together in 0-3 % BSA/PBS;
the two secondary antibodies were also used in a single
solution.
In each experiment, the entire control or neural-crest-
ablated embryo (i.e. all the serial sections) was stained with
one combination of antibodies. At least two control and two
operated embryos were studied in this way for each antibody
combination. Table 1 shows the combinations of primary
antibodies used in single- and double-immunofluorescence
experiments.
Control sections were included in each experiment; in
these, incubation in 3 % BSA/PBS replaced the incubation in
primary antibody.
Electrophoretic characterisation of antigens
We were not able to detect antigens recognised by antibodies
M1B4, 578 or KAF9(1) in immunoblots made from polyacryl-
amide gels of unfractionated somite tissue under either
reducing or nonreducing conditions. For this reason, we had
to resort to affinity-extraction of the antigens from these
tissues. 45 /ig of M1B4 IgG were purified by affinity from
culture supernatant using goat anti-mouse IgG agarose
(Sigma), following the manufacturer's protocol. The bound
IgG was eluted using 0-1 M-glycine and 045 M-NaCl (pH2-4),
Table 1. Combinations of antibodies used for
immunofluorescence studies
M1B4
578
KAF9(1)
HNK-1
20B4
Total = 59
M1B4
4
2
3
18
-
578
2
4
2
5
2
KAF9(1)
3
2
4
5
2
HNK-1
18
5
5
-
4
20B4
_
2
2
4
4
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and the fractions collected were neutralised with a small
volume of lM-Trizma base (Sigma). This purified IgG was
coupled to 0-5 ml CNBr-activated Sepharose-4B (Sigma)
following the manufacturer's instructions.
Strips of somite tissue (with some adherent ectoderm and
endoderm) were dissected from unoperated embryos or from
embryos from which the neural crest had been ablated
36-48 h earlier (as described above). Equivalent regions were
taken from both operated and unoperated embryos, ignoring
the first and last three pairs of somites opposite the operated
region; both control and operated embryos were at stages
18-22. Two types of sample were dissected from younger
embryos. In one, the last four pairs of somites plus some
adherent tissues were dissected from embryos at stages 12-14
and treated identically to the other samples. In the other, the
same region was dissected but the neural tube and notochord
were included in the sample. In all cases, tissues were
collected in PBS containing a cocktail of protease inhibi-
tors: lmM-phenymethylsulphonylfluoride (PMSF; Sigma),
lmM-N-ethyl maleimide (NEM; Sigma), lO^gml"1 soybean
trypsin/chymotrypsin inhibitor (STI; Sigma), lmM-EDTA
and 1 mM-EGTA, and quickly frozen on solid CO2.
The frozen tissue samples were thawed and homogenised in
200 ,ul solubilization buffer, made up of 0-25 % sodium deoxy-
cholate, lOmM-Tris, 150mM-NaCl (pH8-3) containing the
cocktail of protease inhibitors described above. They were
then centrifuged at 11600g for 5min and the supernatants
collected for loading onto the affinity column. Samples were
incubated in the column for 45 min at room temperature, after
which the column was washed with 15 column volumes of
solubilisation buffer containing 300mM-NaCl. Elution was
then performed using a buffer containing 0-1 M-diethylamine,
150mM-NaCl and 0-25% sodium deoxycholate (pHll-5).
100 iA fractions were collected and a protein assay performed
as a dot blot on Immobilon membrane (Millipore) using
AuroDye (Janssen). Protein-containing fractions were pooled
and concentrated by pressure dialysis against 0-1% deoxy-
cholate, 20mM-Tris, 150mM-NaCl, 1 mM-EGTA and lmM-
EDTA(pH8-3).
Approximately equal amounts of protein were loaded per
track of 4-15% SDS-polyacrylamide gradient minigels
(9 cm x 9 cm x 0-5 mm) using the Laemmli (1970) buffer sys-
tem in an apparatus designed as described by Matsudaira and
Burgess (1978). Electrophoresis was performed at 150 V for
90 min, or until the tracking dye was 1-5 cm above the bottom
of the gel. The resulting gels were silver-stained as described
previously (Canning and Stern, 1988; Norris et al. 1989).
14C-labelled, colour-coded molecular weight standards
(Amersham, Rainbow Markers) were run in one or two tracks
in each gel. A track containing a sample of purified mouse
Jl/tenascin was also included in each gel for comparison. This
preparation of Jl/tenascin was prepared by affinity purifi-
cation as described previously (Faissner et al. 1988), using
postnatal mouse brain tissue as starting material. The eluted
fractions were dialysed against water and lyophilised.
Immunoblots of purified mouse brain tenascin were also
made. Each blot included radioactive relative molecular mass
markers and samples of purified Jl/tenascin, under reduced
and non-reduced conditions. Transfer to Immobilon mem-
branes was performed as described previously (Primmett et al.
1989). Each membrane was probed with one of the antibodies
used in this study, namely M1B4, 578 or KAF9(1), and
detected with either rabbit anti-rat followed by gold-labelled
goat anti-rabbit Ig for MAb578, or gold-labelled goat anti-
rabbit Ig for KAF9(1), or gold-labelled goat anti-mouse IgG
for M1B4. All gold-labelled antibodies were purchased from
Janssen (AuroProbe system).
Results
Immunohistochemistry
Identification of neural crest cells with antibodies
20B4 and HNK-1
Monoclonal antibody 20B4 is reported to be specific for
dorsal root ganglion cells and migrating neural crest
cells; it also detects an antigenic determinant in the
ectoderm of chick embryos (Dr J. Denburg; data from
sheet obtained with supernatant supplied from the
Developmental Studies Hybridoma Bank). In our
hands, 20B4 was not as useful as HNK-1 in revealing the
distribution of neural crest cells in the sclerotome
because 20B4 staining was always of lower intensity and
it only recognised a subset of cells stained by HNK-1.
Nevertheless, the overall pattern of staining seen with
this antibody in embryo sections was similar to that seen
with HNK-1.
Jl I tenascin-immunoreactivity
Most of the immunocytochemical procedures involved
double staining, using one antibody directed to J l /
tenascin-related molecules and one directed to neural
crest cells. The combinations of antibodies used in these
experiments are summarised in Table 1. Identical re-
sults were obtained using all three antibodies directed
against Jl/tenascin [M1B4, 578 and KAF9(1)]. This
was confirmed in double-staining experiments combin-
ing the three antibodies, one pair at a time: in every
case, the staining patterns in the rhodamine and fluor-
escein wavelengths were identical.
In all somites of the youngest embryos (stage-13 or
earlier) and in the most caudal 2-3 pairs of (epithelial)
somites of older embryos (stage 16-22), staining was
restricted to the extracellular matrix surrounding each
somite and to the matrix associated with mesenchymal
cells within the lumen of the epithelial somites, as
described by Crossin et al. (1986), Tan et al. (1987) and
Mackie et al. (1988). Also in accordance with Tan et al.
(1987) and Mackie et al. (1988), staining within the
sclerotomes of the most cranial (older) somites of
embryos older than stage 16 was restricted to the rostral
half of each sclerotome; most of the cells expressing
Jl/tenascin immunoreactivity were not HNK-1- or
20B4-positive (Fig. 1 E, F). In addition, Jl/tenascin-
immunoreactive filamentous material was seen close to
the border between adjacent sclerotomes; this material
appeared to be associated with the intersegmental
vessels (Fig. 1 B). Immunoreactive extracellular ma-
terial was also seen between the dermomyotome and
the ectoderm at all segmental levels. Strong staining
was also seen between adjacent dermomyotomes, es-
pecially at the caudal margin of each (Fig. 1 A).
The pattern of staining seen in younger sclerotomes
(the 4-6 most caudal sclerotomes, between 4 and 10
segments rostral to the segmental plate) of embryos
beyond stage 13 was different from that described by
Tan et al. (1987) and by Mackie et al. (1988). In these
young somites, which have already begun to be col-
onised by migrating neural crest cells (Rickmann et al.
Fig. 1. Changes in the expression of Jl/tenascin-related molecules during development of the sclerotome. (A) Coronal
section through the two most caudal sclerotomes of a stage-14 embryo, stained with M1B4 (red) and HNK-1 (green). Note
the intensely HNK-1-positive perinotochordal matrix, and the HNK-1-positive neural crest cells in the rostral (left) half of
the sclerotomes. MlB4-positive material, on the other hand, is more intense in the caudal than the rostral halves.
(B) Sagittal section through two caudal sclerotomes of a stage-15 embryo, stained with HNK-1 (red) and KAF9(1) (green).
More intense KAF9(1) staining is seen in the caudal (right) halves of the sclerotomes, while many HNK-1-positive neural
crest cells have already entered into the rostral halves. KAF9(1) staining is also seen surrounding each somite and near the
intersegmental vessels. (C) Oblique transverse section through a stage-15 embryo, stained with KAF9(1) (green) and HNK-1
(red), about 9 segments cranial to the segmental plate. The section passes through the rostral half of the sclerotome on the
left and through the adjacent caudal half on the right. Note the abundance of KAF9(l)-positive material between the
dermomyotome and the ectoderm, between the neural tube and the sclerotome, and within both halves of the sclerotome.
KAF9(l)-positive material is more abundant in the caudal half at this level. HNK-1-positive cells have entered deep into the
rostral half of the sclerotome. (D) Coronal section through two more rostral sclerotomes (about 12 segments rostral to the
segmental plate) of a stage-15 embryo, stained with HNK-1 (red) and MAb578 (green). MAb578-immunoreactivity begins to
predominate in the rostral half. (E) Coronal section through three more rostral sclerotomes (about 15 segments rostral to
the plate) of a stage-17 embryo, stained with M1B4 (red) and HNK-1 (green). Within the sclerotome, M1B4
immunoreactivity is now confined to the rostral (left) half, except in the most ventromedial portion of the sclerotome,
adjacent to the notochord. (F) Higher power view of one of the sclerotomes shown in (E). HNK-1 (green) and M1B4 (red)
immunoreactivity do not coincide except in very few areas. In each figure, the head of the embryo lies towards the left of
the photograph. Scale bars: 50^m (A-E), 25^m (F). d, dermomyotome; m, myotome; n, notochord; s, sclerotome; t,
neural tube; v, intersegmental vessel.
Fig. 2. Neural crest ablation and expression of Jl/tenascin-related molecules. (A) Low-power view of an oblique coronal
section through a stage-15 embryo after ablation of six segments worth of dorsal neural tube at stage 11, stained with HNK-1
and TRITC-labelled secondary antibody. Note the presence of neural crest cells in most of the sclerotomes in the operated
region. (B) Phase-contrast micrograph of a sagittal section through two neural-crest-free sclerotomes of a stage-16 neural-
crest-ablated embryo. Note that the rostral (left) halves display a reduction in cell number as compared with the
corresponding caudal halves. (C) Same section as in B above, stained with M1B4 (red) and HNK-1 (green). Note the
absence of HNK-1-positive cells, and the predominance of M1B4 immunoreactivity in the caudal half-sclerotome.
(D) Sagittal section through neural crest-free older sclerotomes (about 12 segments rostral to the segmental plate) of a stage-
17 embryo, stained with HNK-1 (red) and KAF9(1). Note the predominance of KAF9(1) immunoreactivity in the caudal
halves of the sclerotomes. [Compare the pattern of staining with that shown in Fig. 1E,F, which passes through the same
level of a similarly-staged but unoperated embryo]. (E) Sagittal section through neural-crest-free sclerotomes of a stage-17
embryo stained with HNK-1 (red) and KAF9(1) (green). In this embryo, both halves of the neural-crest-free sclerotomes
display KAF9(1) immunoreactivity. Scale bars: 100/im in A 50 ,um in B-E. The head of the embryo lies towards the left of
each photograph, a, aorta; d, dermomyotome; n, notochord; t, neural tube.
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1985; Bronner-Fraser, 1986; Teillet et al. 1987), the
caudal half of each sclerotome is more intensely stained
by the antibodies than the rostral half (Fig. 1 A-C). In
about half the cases, moreover, staining was restricted
to the caudal half. The relationship between the distri-
bution of migrating neural crest cells (as revealed by
antibodies HNK-1 and 20B4) and that of Jl/tenascin
immunoreactivity was revealed in double-immunoflu-
orescence experiments (Fig. 1): at this stage in the
development of the somite, when neural crest cells are
starting to invade the sclerotome, Jl/tenascin immuno-
reactivity predominates in the opposite half of the
sclerotome to that occupied by the neural crest cells
(Fig. 1 A-C). Jl/tenascin immunoreactive material in
the sclerotome was most abundant dorsally near the
dermomyotome, where it had a filamentous appearance
(Fig. 1 A, B), and ventrally in the vicinity of the
notochord, where it was associated with the peri-
notochordal sheath. It was also associated with the
basal lamina surrounding the neural tube (Fig. 1 C).
The 4-5 sclerotomes rostral to the 4-6 most recently
formed (situated between the 10th and 15th segment
rostral to the segmental plate) displayed an intermedi-
ate pattern of staining: both halves of these sclerotomes
showed approximately equal levels of immunoreactivity
(Fig. 1 D). The region of the sclerotome that lies
adjacent to the notochord is immunoreactive for J l /
tenascin along the entire rostrocaudal axis (i.e. in both
halves of the sclerotome) rostral to the 10th segment
beyond the segmental plate (e.g. Fig. 1 E).
Neural crest removal
In a preliminary series of experiments, a strip of dorsal
neural tube, 3-15 segments in length, was removed
from a region opposite the caudal paraxial mesoderm.
The operated embryos were then incubated for 36-48 h,
fixed, sectioned and stained with monoclonal antibody
HNK-1 to visualise the distribution of the neural crest
cells and to assess the effectiveness of the operation. In
agreement with earlier investigations (Yntema and
Hammond, 1954; Rickmann et al. 1985; Teillet et al.
1987), we found that neural crest cells are capable of
migrating along the rostrocaudal axis for a distance of
three segments in each direction (e.g. Fig. 2 A). There-
fore, the sclerotomes in the operated region of embryos
in which the neural crest removal spanned six segments
or less always became colonised by HNK-1-immuno-
reactive cells.
In another series of preliminary experiments, a
length equivalent to 3-15 segments of the entire dorso-
ventral extent of the neural tube was removed, and the
distribution of HNK-1-positive cells examined in sec-
tions after 36-48h incubation. In these embryos, the
HNK-1-positive cells did not migrate rostrocaudally
from the edges of the operation site. However, the
integrity of the somites opposite the operated region
was affected: the somites were always fused in the
midline and the segmental arrangement of somitic
mesoderm was often disrupted.
For these reasons, all our neural crest ablation
experiments were performed on embryos from which
the dorsal half of the neural tube was excised over
10-15 segments. In these embryos, after 36-48 h post-
operative incubation, the somites appeared normal and
at least five sclerotomes opposite the operated region
were always found to be devoid of HNK-1-immuno-
reactive cells.
The distribution of M1B4, MAb578 or KAF9(1)
staining in sclerotomes devoid of neural crest cells at
stages 18-22 was rather different from that seen in
unoperated sclerotomes, and different from the pattern
reported by Tan et al. (1987). Young sclerotomes in the
operated region displayed immunoreactivity predomi-
nantly in the caudal half of the sclerotome (Fig. 2 C) (as
in unoperated embryos). However, in most embryos
(39/56; 70%), this pattern was unchanged in older
sclerotomes opposite the operated region (Fig. 2 D). In
some embryos (13/56; 23 %), immunoreactive material
was seen in both halves of the sclerotomes (Fig. 2 E), in
three embryos (5%) the sclerotomes appeared to be
devoid of immunoreactivity in the operated region and
in one embryo staining was restricted to the rostral
halves of sclerotomes devoid of HNK-1-immuno-
reactive cells.
To investigate whether the difference between oper-
ated and control embryos in the pattern of Jl/tenascin
immunoreactivity is due to a contribution of the neural
crest cells or to a developmental delay of the operated
embryos, three embryos from which the neural crest
had been removed as described above were incubated
for a total of 3-5 days after the operation, until they had
reached stages 25-27. The pattern of Jl/tenascin immu-
noreactivity in these embryos was similar to that seen in
operated embryos incubated to stages 18-22: in every
case, Jl/tenascin immunoreactive material was found
in both halves of the neural-crest-free sclerotomes.
Biochemical characterisation of Jl/'tenascin-related
antigens
Purification of Jl/tenascin-related antigens was per-
formed using a column of immobilised M1B4 IgG,
followed by SDS-polyacrylamide gel electrophoresis
(SDS-PAGE) to identify the eluted antigens under
nonreducing conditions.
In preliminary experiments, the specificity of the
three antibodies (M1B4, KAF9(1) and MAb578) for
Jl/tenascin-related molecules was assessed in immuno-
blots of a sample of purified mouse brain tenascin
separated by SDS-PAGE under nonreducing con-
ditions. Silver-stained gels obtained from this sample
showed a characteristic pattern of bands, summarised in
Table 2. In immunoblots, both KAF9(1) and MAb578
recognised many of the bands seen in silver-stained
gels, of which a band of Mr = 230xl03 was most
prominent (Fig. 3). The avian-specific antibody M1B4,
by contrast, did not recognise any components in this
mouse tenascin preparation.
In samples of somite tissue obtained from unoperated
embryos at stage 18-22, several bands were seen in
silver-stained gels of eluted material. Their Mr ranged
from 39 to 230xl03 (Fig. 4). Table 2 summarises the
relative molecular masses of the polypeptides seen in
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Table 2. Apparent relative molecular masses of Jl/tenascin-related molecules (Mr x JO 3)
Mouse brain
tenascin
>300
230
185
140
70
5g
•47
39
stage-18
unoperated
230
195
150
140
130
120
115
100
94/96
78
70
58
52
49
45
39
stage-18
— crest
105/110
70
58
52
49
39
st.13 epith.somites
+ NT & notochord
190
140
130
125
120
105/110
94/96
78
70
58
52
49
39
st. 13 epith.somites
- NT & notochord
160
94
78
70
58
52
49
39
these gels. The highest relative molecular mass com-
ponent seen appeared to be similar to the major
component (c. 230xl03) found in silver-stained gels and
immunoblots of samples of purified mouse tenascin
(Figs 3,4). The sample of purified tenascin contained a
higher relative molecular mass component which may
represent a multimer (hexamer, Mr approximately
MrX 10
200-
116 -
66 -
4 5 - —,
12 3 4 5 6
Fig. 3. Western blots of mouse brain tenascin showing
specificity of antibodies used for Jl/tenascin.
Immunoreactivity was detected using the AuroProbe
system. Odd-numbered lanes: non-reduced mouse brain
tenascin. Even-numbered lanes: reduced mouse brain
tenascin. Lanes 1 and 2 were probed with KAF9(1). Lanes
3 and 4 were probed with MAb578. Lanes 5 and 6 were
probed with M1B4 (which is specific for avian tenascin).
106 = 'hexabrachion'; Chiquet and Fambrough, 1985;
Mackie et al. 1988), but this was not seen in samples
obtained from chick embryo somites.
Samples obtained from neural-crest-ablated embryos
displayed a different pattern of silver-stained bands
after elution from the M1B4 column (Table 2). The six
bands of highest relative molecular mass (120, 130,140,
150, 195 and 230X103) seen in unoperated embryos
were missing. Some lower relative molecular mass
components were also absent. Some bands, however,
were present in samples from both unoperated and
neural-crest-ablated embryos (A/r 39, 49, 52, 58 and
70X103).
Antigens were also detected in samples of epithelial
somites from stage-13 to -14 embryos subjected to
affinity purification through the M1B4 column; some
differences were found between those samples that
included the neural tube and notochord and those that
did not. Gels are shown in Fig. 4 and the molecular
masses of the bands summarised in Table 2. The pattern
of bands seen in this material was different from that
seen in similarly treated sclerotome from unoperated
embryos. The most conspicuous difference was the
absence of the 230X103 component, as seen in neural-
crest-ablated embryos. However, other components
absent from neural-crest-ablated sclerotomes were seen
in the epithelial somite preparations (Table 2).
Discussion
We have used two monoclonal antibodies (M1B4 and
578) and one antiserum [KAF9(1)] to study the ex-
pression of Jl/tenascin-related molecules in somite
tissue of the chick embryo. Young somites are sur-
rounded by immunoreactive material, while old sclero-
tomes display expression of these molecules predomi-
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Mrx1CT3
200-*—'
I
'• • .-4
116 -
92-5 -
66-H
45* *
31 -
I
Fig. 4. Silver-stained gels of somite
material purified by affinity to M1B4
antibody. Lane 1, relative molecular
mass markers. Lane 2, mouse brain
tenascin (nonreduced; not affinity
purified through M1B4 column).
Lane 3, sclerotomes from unoperated
stage-18 embryos. Lane 4,
sclerotomes from neural-crest-ablated
stage-18 embryos. Lane 5, stage-13
epithelial somites with neural tube
and notochord. Lane 6, stage-13
epithelial somites without other axial
tissues. The molecular masses of the
bands seen in these samples are given
in Table 2.
nantly in their rostral halves, as previously described by
other authors (Tan et al. 1987; Mackie et al. 1988).
Sclerotomes at intermediate stages of development,
however, often display immunoreactivity in the op-
posite (caudal) half of the sclerotome to that occupied
by neural crest cells (Fig. 5). Our results therefore
differ from those of Tan et al. (1987), who stated that 'at
the time of sclerotome formation, cytotactin began to be
expressed in the rostral half of the sclerotome, and neural
crest cell invasion occurred in this area\ and from those
of Mackie et al. (1988). Also in contrast to Tan et al.'s
(1987) observations, we find that after neural crest
ablation, immunoreactivity is not restricted to the
rostral half of the sclerotome. SDS-PAGE of affinity-
purified somite tissue reveals a characteristic pattern of
bands of various relative molecular masses, including
two bands at about 195 and 230xl03, as described for
cytotactin, Jl-200/220 and the monomeric form of
tenascin (Chiquet and Fambrough, 1984; Grumet et al.
1985; Kruse et al. 1985; Vaughan et al. 1987; Faissner et
al. 1988; Hoffman et al. 1988). After ablation of the
neural crest, somite material analysed in the same way
still shows some of the bands seen in unoperated
embryos, but several components are missing, including
the six of highest relative molecular mass
(120-230 xlO3).
Ablation of the neural crest
In agreement with other workers (e.g. Yntema and
Hammond, 1954; Rickmann et al. 1985; Teillet et al.
1987), we have found that ablation of a short length (six
segments or less) of the dorsal half of the neural tube
allows neural crest cells from the cut ends of the tube to
colonise the rostral halves of the sclerotomes in the
operated region. Under these conditions, neural crest
cells appear to be able to migrate for about three
segments along the rostrocaudal axis. If the whole
thickness of the neural tube is ablated, moreover, the
integrity of the adjacent somites is disrupted, as
reported by Strudel (1955) and Teillet and Le Douarin
(1983). In order to obtain neural-crest-free and mor-
phologically normal sclerotomes, therefore, it was
necessary to extirpate a length of dorsal neural tube at
least seven segments in length.
In Tan et al.'s (1987) experiments, the neural crest
was ablated by removing a six-segment length of an
unspecified depth of neural tube. In our hands, if only
the dorsal portion of the tube was removed, such an
operation would have allowed neural crest cells to
colonise all the sclerotomes in the operated region. If,
on the other hand, the whole depth of neural tube was
removed, the operation would have caused the somites
to display abnormal segmentation. Moreover, Tan et al.
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©
HNK-1 staining
M1-B4 staining
unoperated
neural crest removed
Oh
somite
formation
10 h
sclerotome
formation; crest
enters somite
6 somites
(epithelial)
12-15 segments
36 -48 h
motor axons
enter somite
Fig. 5. Diagram summarising the changes in the distribution of Jl/tenascin immunoreactivity in relation to the onset of
neural crest migration and motor axon outgrowth through the sclerotome in the presence and absence of neural crest cells.
Each of the two embryos is depicted at about stage 16, with its caudal end towards the left of the picture, so that younger
somites appear towards this end. The upper diagram shows the distribution of neural crest cells and of Jl/tenascin
immunoreactivity in an unoperated embryo, while the lower cartoon illustrates the pattern of Jl/tenascin after neural crest
removal. In this lower diagram, the results are presented as if the neural crest were absent over the entire extent of the
embryonic axis. The line below the diagrams gives an approximate indication of the time scale of the changes that occur and
points to the level at which the motor axons are starting to enter the sclerotome.
(1987) ablated the neural tube opposite the last six pairs
of segments of 15- to 18-somite embryos; at this stage,
the most rostral one or two of these pairs already
contain neural crest cells (Rickmann et al. 1985).
Tan et al. (1987) argue that, after ablation of the
neural crest, cytotactin expression in the sclerotomes is
similar to that seen in unoperated embryos, that is,
restricted to the rostral half of each sclerotome. Our
results do not agree with this interpretation. While the
pattern of expression of Jl/tenascin-related molecules
is still segmental after ablation of the neural crest,
immunoreactivity fails to become restricted to the
rostral halves of the sclerotomes in the absence of
neural crest cells.
Molecular nature of Jl/tenascin-related antigens
Removal of the neural crest leads to a change in the
distribution of Jl/tenascin immunoreactivity and in the
proportions of the various molecules extracted by
affinity to M1B4 antibody. In the absence of neural
crest cells, the higher relative molecular mass bands
(120-230X103) characteristic of cytotactin, Jl-160/180,
Jl-200/220 and monomeric tenascin are absent, and
lower relative molecular mass components predomi-
nate. Epithelial somites from younger embryos do not
display the higher molecular mass (230 xlO3) band.
Many of the lower relative molecular mass components
are present in a purified sample of tenascin prepared
from mouse brain.
Several possibilities must be considered in attempting
to identify the various components seen in gels. First, it
is possible that at least some of them are degradation
products of the larger macromolecule. Although this is
probably responsible for some of the lower molecular
mass components, it seems unlikely to be the only
factor accounting for our results, because expression of
the higher relative molecular mass components can be
dissociated from expression of the lower relative mol-
ecular mass bands (in the absence of neural crest and in
younger somites). While it might be argued that the
operation of neural crest removal itself releases proteo-
lytic enzymes, control embryos destined for biochemi-
cal investigations were subjected to cuts in and around
the neural tube (without removing the neural crest).
Moreover, sections of operated embryos did not show
any differences in the pattern of immunoreactivity
outside the operated region, suggesting that diffusible
proteases are not released from the operation site.
A second possibility to consider is that the smaller
components are not related to Jl/tenascin directly, but
are ligands for molecules containing the epitope recog-
nised by M1B4, which copurify with M1B4 antigens
during affinity extraction. However, staining is seen
with all three antibodies in the absence of neural crest
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cells and in young somites, despite the finding that the
higher molecular mass components are absent from
these tissues.
A final possibility is that the molecules recognised by
the antibodies used in this study are not single mol-
ecules but rather complexes, or associations of several
molecules of various molecular masses. The possibility
of a single promiscuous epitope present on many
different molecules can probably be excluded because
the two monoclonal antibodies (M1B4 and 578) recog-
nise different epitopes. It is possible, however, that the
multiple bands seen in silver-stained gels from affinity-
purified Jl/tenascin-related molecules represent whole
portions of the larger molecule(s), which may be used
by the embryo in different contexts, for example as
precursors for the assembly of the higher molecular
mass components.
The results of this study therefore suggest that a
group of molecules, immunologically related to J l /
tenascin, is expressed in the sclerotome of the chick
embryo, and that the expression of the characteristic
120-230xl03 components may be regulated indepen-
dently of the expression of the lower relative molecular
mass forms. Further speculations on their function will
have to await characterisation by antibodies that can
distinguish between them, as well as knowledge of their
amino-acid sequence.
Are Jl/tenascin-related molecules produced by neural
crest or by sclerotome cells?
It was found both by Tan et al. (1987) and by Mackie et
al. (1988) that, in vitro, neural crest cells cultured alone
do not produce cytotactin or tenascin, while somite
cultures do. However, it is not clear whether Tan et al. 's
(1987) somite cultures contained neural crest cells,
which begin to colonise the somitic mesenchyme as
soon as the sclerotome can be distinguished (see Rick-
mann et al. 1985; Bronner-Fraser, 1986; Teillet et al.
1987). Jl/tenascin immunoreactivity in older sclero-
tomes is localised both to some of the cells expressing
the HNK-1 and/or 20B4 epitopes (the two neural crest
markers) and to some not expressing them (Fig. 1 E,
F). Since recently formed epithelial somites, which do
not yet contain any neural crest cells, already contain
cytotactin and tenascin immunoreactivity (Tan et al.
1987; Mackie et al. 1988) within the somite lumen,
Mackie et al. (1988) suggested that the somite cells
themselves secrete these molecules into the lumen. Our
results suggest that the Jl/tenascin-immunoreactive
material detected in and around epithelial somites is
due to molecular components different from those
detected in older sclerotome/neural crest tissue. Taken
together, therefore, these findings suggest that the
presence of neural crest cells is required for expression
of the higher molecular mass Jl/tenascin-related com-
ponents. One possibility, suggested by our results on
the relative molecular masses of the components iso-
lated from epithelial somite tissue samples with and
without neural tube/notochord, is that the somite cells
produce some of the precursor chains of the tenascin
molecule while the neural crest or other notochord or
neural tube-derived tissues supply other chains. This
accounts for our conclusion that both the neural crest
and the somite are required for expression of the higher
molecular weight components of Jl/tenascin.
Do Jl/tenascin-related molecules play a controlling
role in neural crest migration and/'or axon ougtrowth
through the sclerotome?
Our findings appear to resolve the paradox presented
by the results of Tan et al. (1987), Mackie et al. (1988)
and Halfter et al. (1989). These authors suggested that
cytotactin and tenascin, respectively, are restricted to
the rostral half of each sclerotome, but that these
molecules are inhibitory to neural crest migration and
spreading in vitro. Our results show that, at the time of
onset of neural crest migration through the rostral
halves of sclerotomes in embryos between stages 13 and
16, Jl/tenascin-related molecules are present in the
caudal halves of the sclerotomes, a finding that is more
consistent with an inhibitory role of these molecules for
neural crest migration in vivo. It may be interesting to
note in this context that the notochord, which inhibits
the migration of neural crest cells (Newgreen etal. 1986;
Guillory and Bronner-Fraser, in preparation; Stern and
Bronner-Fraser, in preparation), is immunoreactive
with antibodies that recognise Jl/tenascin-related mol-
ecules (Fig. 1 B-C, E-F); it is therefore possible that
these molecules contribute to the notochordal inhi-
bition of neural crest migration.
The distribution of the cytotactin-binding proteogly-
can ('CTB proteoglycan'), reported by Tan etal. (1987)
to become localised to the caudal halves of the sclero-
tomes, should also be considered. Because CTB pro-
teoglycan binds peanut lectin (PNA), and because this
lectin has been shown to stain the caudal halves of the
sclerotomes of the chick embryo (Stern et al. 1986),
CTB proteoglycan could be responsible for the pattern
of staining seen with PNA. However, peanut lectin
binding is never seen in both halves of the sclerotome,
as described for CTB proteoglycan at early stages of
somite development. Furthermore, preliminary exper-
iments have shown that at the stages of development
when PNA binding to caudal sclerotome cells is seen,
several PNA-binding molecules of diverse molecular
masses from 17x10 upwards are expressed differen-
tially in the two halves of the sclerotome (Davies,
Cook, Norris, Keynes and Stern, in preparation).
Neither of these observations supports the hypothesis
that CTB proteoglycan is responsible for the pattern of
PNA staining in the sclerotome.
If cytotactin/Jl/tenascin played a controlling role in
determining the migration pathways of trunk neural
crest cells, one would expect their temporal and spatial
patterns to correlate. However, this is not the case.
When the first neural crest cells enter the rostral halves
of the first sclerotomes to form (at about the 8 somite
stage, stage-9; Thiery etal. 1982; Rickmann etal. 1985;
Bronner-Fraser, 1986; Lim et al. 1987; Loring and
Erickson, 1987; Teillet et al. 1987; Tosney, 1988), these
sclerotomes display very little, if any, cytotactin/Jl/
tenascin immunoreactivity (Crossin et al. 1987; Tan et
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al. 1987; Mackie et al. 1988 and the present obser-
vations). Neural crest cells entering newly formed
sclerotomes between stage-13 and stage-16 do so when
these sclerotomes display immunoreactivity mainly in
their caudal halves (present observations). Finally,
neural crest cells entering the sclerotomes that form
after stage-16 do so when Jl/tenascin immunoreactivity
begins to predominate in the rostral halves of these
sclerotomes (Tan et al. 1987; Mackie et al. 1988 and the
present observations). Thus, some neural crest cells
enter sclerotomes devoid of Jl/tenascin or the rostral
halves of sclerotomes expressing Jl/tenascin in their
caudal halves, while yet others enter the Jl/tenascin-
containing halves. These results argue strongly that
cytotactin/Jl/tenascin-related molecules cannot be
solely responsible for the segmented pattern of mi-
gration of neural crest cells through the sclerotome.
Motor axon outgrowth through the rostral half-
sclerotome, however, begins at about stage 17 (Keynes
and Stern, 1984), shortly after the onset of cytotactin
and of Jl/tenascin expression in the rostral half-sclero-
tome. Is it possible that these molecules determine the
segmented pattern of motor axon outgrowth? Our
results argue strongly that this is not the case. Ablation
of the neural crest leads to a change in the spatial
pattern of expression of Jl/tenascin-related molecules
in the sclerotome, but the same operation does not
disturb the pattern of axon outgrowth through the
rostral half-sclerotome (Rickmann et al. 1985). There-
fore, it can be concluded that Jl/tenascin-related mol-
ecules are not responsible for the segmented pattern of
either neural crest migration or motor axon outgrowth.
There remains the possibility, nevertheless, that
Jl/tenascin-related molecules play a role in the sub-
sequent morphogenesis of neural crest derivatives, for
example during dorsal root ganglion formation. This
possibility is suggested by our finding that the neural
crest appears to participate in the production of mol-
ecules capable of inhibiting its own migration. The time
interval between the entrance of neural crest cells into
the rostral half of a sclerotome and the change in the
localisation of Jl/tenascin-immunoreactivity appears to
be equivalent to about 8-10 somites, in turn equivalent
to about 12-15 h. It is possible that such a mechanism
acts to limit the number of neural crest cells entering the
sclerotome. It may also prevent the further migration of
neural crest cells in preparation for dorsal root ganglio-
genesis, which occurs at about stage 21 (Lallier and
Bronner-Fraser, 1988), and may therefore determine a
balance between the number of neural crest cells
destined to contribute to the autonomic nervous system
and the number destined to form sensory neurones.
Conclusions
Our results provide strong evidence that Jl/tenascin-
related molecules are not responsible for the segmented
pattern of neural crest cell migration or motor axon
outgrowth. Rather, they suggest that the neural crest
modulates the expression of these molecules in the
sclerotome, although it is not clear whether the neural
crest itself is responsible for their production. J l /
tenascin-related molecules seem to have an inhibitory
effect on neural crest migration both in vivo and in vitro
and could play a role in gangliogenesis and the later
morphogenesis of neural crest derivatives. Our results
suggest that the names 'tenascin', 'Substrate Adhesion
Molecules (SAMs)' and 'cytotactin' given to these mol-
ecules (e.g. Grumet et al. 1985) do not suit their
apparent functions as judged by their pattern of ex-
pression in the developing chick embryo. While these
terms suggest strong adhesion, cellular affinity and
attraction of migrating cells, our results point towards a
possible inhibitory role of these molecules in patterning
the peripheral nervous system after the initial stages of
its development.
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